Obstetrics Investigations and Management Flashcards
Investigations for suspected hyperemesis gravidarum
- Examination => signs of dehydration
- Basic observations => reduced BP, high HR, weight and calculate BMI
- Urine dipstick à ketones
- Bloods:
- FBC => increased hct
- U&Es => dehydration
- PUQE score
Mx of hyperemesis gravidarum
- Consider admission for the following patients:
- Women unable to keep oral anti-emetics down
- Continued N&V associated with ketonuria +/- >5% weight loss despite oral anti-emetics
- Confirmed/suspected co-morbidity e.g. UTI
- IV fluid resuscitation and correction of electrolyte abnormalities (usually with KCl)
- IV antiemetics
- 1st line = Cyclizine or promethazine
- 2nd line = metoclopramide/ondansetron
- Thiamine supplementation
- Offer VTE prophylaxis with LMWH
Associations for hyperemesis
- multiple pregnancies
- trophoblastic disease
- hyperthyroidism
- nulliparity
- obesity
Smoking associated with decreased risk
Ddx for pre eclampsia
- Pre-eclampsia
- Gestational HTN
- Essential HTN
Mx of eclampsia
- ABC approach
- Labetalol + IV Magnesium sulphate
- Prevent seizures in severe pre-eclampsia
- Treat seizures once they develop
- 4g loading dose
- 1g/hour infusion 24hrs after last fit
- Recurrent fits => further 2-4g over 5-15 mins
- Monitor urine output, reflexes, RR and oxygen sats
labetalol: 1V 50 MG BOLUS (max of 4) CAN ALSO GIVE 200mg PO
First-line treatment for magnesium sulphate induced respiratory depression
Calcium gluconate
10% 10mls over 10mins
Measure sats, RR , ECG
RF for pre eclampsia
High Risk Factor:
- HTN during previous pregnancy
- CKD
- Autoimmune SLE/antiphospholipid
- T1DM/T2DM
- Chronic HTN
Moderate Risk Factor:
- First pregnancy
- >40 years,
- Pregnancy interval 10+ years
- BMI 35+ at booking
- FH of pre-eclampsia
- Multiple pregnancy
Mx of HELLP
- ABC approach
- 1st line in confirmed HELLP is to deliver
- IV Magnesium sulphate
How is high-risk Pre eclampsia managed?
- 75 mg OD aspirin from 12 weeks until birth
For a patient with pre-eclampsia when would you consider delivery?
- Uncontrollable BP despite 3+ antihypertensive classes at full dose
- Maternal sats <90%
- HELLP
- Neuro features
- Placental abruption
- Reversed end-diastolic flow in umbilical artery doppler
- Non-reassuring CTG
- Stillbirth
Ix for suspected Obstetric cholestasis
- Examination => jaundice, excoriation marks, SFH
- Basic observations => BP, HR, temp
- Urine dipstick
-
Bloods:
- LFTs
- Bile acids
- WCC
- Clotting screen – prolonged PT
- CTG
- Abdo USS
Mx of Obstetric cholestasis
- Conservative:
- Topical emollients
- Wear loose fitting clothing
- Medical:
- Ursodeoxycholic acid
- Vit K supplementation
- Monitoring:
- Obstetrician led care
- Regular LFTs and more frequent scans
- Safety net about reduced fetal movements
- Offer induction at 37 weeks
Differentials for PV bleeding in pregnancy
- Placenta praevia
- Placental abruption
- Vasa praevia
- Bloody show
- Cervical ectropion
Ix for PV bleeding
- A to E approach
- Examination – signs of anaemia, tense and tender abdomen
- Basic observations – haemodynamic stability
- CTG
- TVUSS
- Bloods:
- FBC
- Group and save
- Coagulation profile à DIC
- Kleihauer test
Mx of PV bleeding
- A to E approach (IV access and fluid resuscitation)
- Admit until bleeding stops for 24 hours
- <34 weeks administer steroids and consider tocolytics (not in abruption)
- Anti-D prophylaxis
- Continuous fetal monitoring
- EMCS if fetal distress/mother remains haemodynamically unstable
- If low-lying placenta at 32 weeks then repeat TVUSS at 36 weeks
- Deliver:
- If uncomplicated PP: ELCS at 36 weeks onwards
- If placenta accrete spectrum: ELCS at 35 weeks onwards
- Abruption/vasa praevia with fetal or maternal compromise: EMCS
- Stable abruption >34 weeks: consider ELCS or vaginal delivery with active mx of 3rd stage of labour
Ddx for abdo pain
- Placental abruption
- Premature labour
- Braxton-Hick’s contractions
Ix for abdo pain
- A to E approach
- Examination – signs of anaemia, tense and tender abdomen
- Basic observations – haemodynamic stability
- CTG
- TVUSS
- Bloods:
- FBC
- Group and save
- Coagulation profile à DIC
- Kleihauer test
Ix for suspected VTE in pregnancy
DVT
- GE: Unilateral lower limb oedema, erythema, tenderness, low grade pyrexia
- Duplex USS
PE
- GE: tachycardia, tachypnoea, low grade pyrexia, reduced O2 saturation, cardiorespiratory collapse
- Chest auscultation: reduced air entry, creps
- Cardiovascular: Loud P2
- ABG: hypoxia and hypocapnia
- ECG (sinus tachy + S1Q3T3) + CXR
- If DVT suspected also duplex USS
- If CXR abnormal à CTPA in preference to V/Q
- If V/Q or CTPA normal but clinical suspicion high repeat or use alternative Ix
- Bloods: FBC, U&Es, LFT, Clotting
Risk of CTPA or V/Q scan in pregnancy
- V/Q has slightly increased risk of childhood cancer
- CTPA has higher risk of maternal breast cancer
- In both situations, the absolute risk is very small
Mx of VTE in pregnancy
- LMWH (enoxaparin) titrated against booking weight
- Treat upon clinical suspicion whilst awaiting results
- If USS negative then discontinue but repeat USS on day 3 and 7
- Continue for the rest of pregnancy
- Discontinue 24 hrs before delivery
- Do not give until 4 hours after spinal
- Continue 6/52 after delivery or until 3 months Tx in total
- Monitor platelets and peak anti-Xa levels
- Massive PE
- A to E approach
- MDT
- IV unfractionated heparin
- Consider thrombolysis/thrombectomy
Ix for DM in Preganancy
- Examination – SFH, signs or pre-eclampsia, BP, HR
- Urine dip => glucose, proteinuria
- Bloods:
- FBC
- Fasting blood glucose/OGTT à followed by capillary glucose monitoring
- TFTs
- LFTs
- Monitoring:
- CTG
- Serial USS scans for growth and liquor volume
Management of Chronic HTN in pregnancy
- Aim for target BP 135/85
- Switch from ACEi/ARBs to labetalol
- 2nd line = Nifedipine
- 3rd line = Methyldopa (stop within 2 days after birth)
- Placental growth factor testing 20-35 weeks
- Anti-hypertensive review 2 weeks post delivery
Management of Gestational HTN
- Aim for target BP 135/85
- BP monitoring twice a week and dipstick proteinuria tests
- Placental growth factor testing if pre-eclampsia suspected 20-35 weeks
- Labetalol or nifedipine if contra-indicated
- Reduce anti-HTN if BP<130/80 post-natally
Management of previous diabetes
-
Preconceptual:
- Optimisation of glucose control
- Folate 5mg
-
Medical:
- Optimise diet
- Consider converting oral hypoglycaemic to insulin
- Likely to require increasing doses of insulin
-
Pregnancy:
- Capillary blood glucose monitoring (monthly HbA1c is offered)
- Monitor for pre-eclampsia à aspirin 75mg OD from 12 weeks
- Serial USS for foetal growth
-
Delivery:
- Sliding scale in labour (38 weeks)
- MDT – if large then recommend C-section
-
Postpartum:
- Return to pre-pregnancy doses of medications immediately to avoid hypos
- Start feeding neonate within 30 mins and fed frequently to prevent hypoglycaemia
Management of GDM
- Medical:
- Diet/exerecise control for 2 weeks
- Metformin +/- insulin
- > 7 fasting start insulin immediately
- Glibenclamide should only be offered for women who cannot tolerate metformin
- Pregnancy/delivery: As for pre-existing
- Postpartum: Stop insulin after delivery, fasting blood glucose measured at 6/52 postpartum
Risk Factors for GDM
- previous baby >4.5kg
- BMI >30
- Race
- Polyhydramnios
- previous GDM
- previous unexplained stillbirth
- 1st degree relative with DM